AstraZeneca PLC (AZN)
193.03
+5.87
(+3.14%)
USD |
NYSE |
Feb 06, 16:00
191.50
-1.53
(-0.79%)
Pre-Market: 06:02
AstraZeneca SG&A Expense (TTM) : 568.96M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| GSK Plc | 11.99B |
| Biodexa Pharmaceuticals Plc | 5.354M |
| Mereo BioPharma Group Plc | 25.26M |
| Amgen, Inc. | 7.05B |
| Regeneron Pharmaceuticals, Inc. | 2.70B |